Literature DB >> 26975916

Anti-CCP: a truly helpful rheumatoid arthritis test?

Emélie Braschi1, Kam Shojania2, G Michael Allan3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26975916      PMCID: PMC4984588     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

1.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.

Authors:  Penny F Whiting; Nynke Smidt; Jonathan A C Sterne; Roger Harbord; Anya Burton; Margaret Burke; Rebecca Beynon; Yoav Ben-Shlomo; John Axford; Paul Dieppe
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

Review 3.  The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis--a systematic review.

Authors:  J P Riedemann; S Muñoz; A Kavanaugh
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 4.  Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review.

Authors:  Monika Schoels; Claire Bombardier; Daniel Aletaha
Journal:  J Rheumatol Suppl       Date:  2011-03

Review 5.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

Review 6.  Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  A Budhram; R Chu; S Rusta-Sallehy; G Ioannidis; J A Denburg; J D Adachi; D A Haaland
Journal:  Lupus       Date:  2014-07-02       Impact factor: 2.911

Review 7.  Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.

Authors:  Kunihiro Nishimura; Daisuke Sugiyama; Yoshinori Kogata; Goh Tsuji; Takashi Nakazawa; Seiji Kawano; Katsuyasu Saigo; Akio Morinobu; Masahiro Koshiba; Karen M Kuntz; Isao Kamae; Shunichi Kumagai
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

Review 8.  The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates.

Authors:  Elias Zintzaras; Afroditi A Papathanasiou; Dimitrios C Ziogas; Michael Voulgarelis
Journal:  BMC Musculoskelet Disord       Date:  2012-06-25       Impact factor: 2.362

9.  A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis.

Authors:  Peter Taylor; Juliane Gartemann; Jeanie Hsieh; James Creeden
Journal:  Autoimmune Dis       Date:  2011-09-11

Review 10.  The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis.

Authors:  A A Jilani; C G Mackworth-Young
Journal:  Int J Rheumatol       Date:  2015-03-04
  10 in total
  7 in total

1.  A Study on Association Between Protein Carbonyl and Anti-cyclic Citrullinated Peptide Antibody in Rheumatoid Arthritis: Introducing a New Supplementary Biomarker.

Authors:  Sahar Khorasani; Nadia Boroumand; Abdolmomen Ghaeni Pasavei; Maryam Sahebari; Seyed Isaac Hashemy
Journal:  Indian J Clin Biochem       Date:  2019-03-05

2.  Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients.

Authors:  Krzysztof Bonek; Ewa Kuca Warnawin; Anna Kornatka; Magdalena Plebańczyk; Tomasz Burakowski; Włodzimierz Maśliński; Małgorzata Wisłowska; Piotr Głuszko; Marzena Ciechomska
Journal:  Biomedicines       Date:  2022-04-13

3.  Individuals at risk for rheumatoid arthritis harbor differential intestinal bacteriophage communities with distinct metabolic potential.

Authors:  Mihnea R Mangalea; David Paez-Espino; Kristopher Kieft; Anushila Chatterjee; Meagan E Chriswell; Jennifer A Seifert; Marie L Feser; M Kristen Demoruelle; Alexandra Sakatos; Karthik Anantharaman; Kevin D Deane; Kristine A Kuhn; V Michael Holers; Breck A Duerkop
Journal:  Cell Host Microbe       Date:  2021-05-05       Impact factor: 21.023

4.  Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity.

Authors:  Massoud Saghafi; Mandana Khodashahi; Nayyereh Saadati; Azita Azarian; Zahra Rezaieyazdi; Maryam Salehi; Maryam Sahebari
Journal:  Electron Physician       Date:  2017-12-25

5.  Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis.

Authors:  Mevludin Mekic; Emina Hadzigrahic; Alen Dzubur
Journal:  Mater Sociomed       Date:  2020-09

Review 6.  IL-20 bone diseases involvement and therapeutic target potential.

Authors:  Hsiao-Hsuan Wang; Yu-Hsiang Hsu; Ming-Shi Chang
Journal:  J Biomed Sci       Date:  2018-04-24       Impact factor: 8.410

7.  Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.

Authors:  Nathalie Carrier; Artur J de Brum-Fernandes; Patrick Liang; Ariel Masetto; Sophie Roux; Norma K Biln; Walter P Maksymowych; Gilles Boire
Journal:  RMD Open       Date:  2020-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.